Assessment for Implementation Methods in Sepsis (AIMS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mitchell Levy, MD
- Phone Number: 401-444-4000
- Email: mitchell_levy@brown.edu
Study Contact Backup
- Name: Lori Harmon, RRT, MBA, CPHQ
- Phone Number: 847-493-6403
- Email: lharmon@sccm.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Recruiting
- Rhode Island Hospital
-
Contact:
- Mitchell Levy, MD
- Phone Number: 401-444-4000
- Email: mitchell_levy@brown.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults >=18
- Patient meets criteria for time zero (sepsis within 6 hours of ED triage and the 3 criteria-infection, 2 SIRS and 1 or more organ dysfunctions, must be met within 3 hours of each other.
Exclusion Criteria:
- Last admission for patients admitted to same hospital once
- Pregnant women
- All transfers from another hospital
- Individuals who are made comfort care only within 6 hours of admission to ED
- Moribund patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Hour-1 Bundle
If the patient meets 2+ SIRS and chief complaint criteria, a second BPA may be triggered, which displays to the provider.
The second alert identifies patients who progress to organ failure based on lab results, or who have a recorded instance of hypotension.
When this alert appears, an automatic counter will begin and serve as our Sepsis Time Zero.
The provider will receive sepsis order sets and guided to the Sepsis Navigator.
The navigator will allow them to review relevant patient data, reference sepsis guidelines, and keep tabs on a live-updating sepsis checklist to ensure they complete each element in order and on time.
Following identification in the ED, both study arms will receive the same bundle (see below).
The only difference will be the timing: For the Hour-1 bundle, all interventions in the bundle must be initiated within 1 hour.
|
Intervention initiated within 1 hour or 3 hours of presentation depending on the Arm: 1. Measure lactate level.
2. Obtain blood cultures before administering antibiotics.
3. Administer broad-spectrum antibiotics.
4. Begin rapid administration of 30ml/kg crystalloid for hypotension or lactate greater than or equal to 4mmol/L. 5. Apply vasopressor if hypotensive during or after fluid resuscitation to maintain a mean arterial pressure greater than or equal to 65 mm Hg.
|
|
ACTIVE_COMPARATOR: 3-Hour Bundle
If the patient meets 2+ SIRS and chief complaint criteria, a second BPA may be triggered, which displays to the provider.
The second alert identifies patients who progress to organ failure based on lab results, or who have a recorded instance of hypotension.
When this alert appears, an automatic counter will begin and serve as our Sepsis Time Zero.
The provider will receive sepsis order sets and guided to the Sepsis Navigator.
The navigator will allow them to review relevant patient data, reference sepsis guidelines, and keep tabs on a live-updating sepsis checklist to ensure they complete each element in order and on time.
Following identification in the ED, both study arms will receive the same bundle (see below).
The only difference will be the timing: For the 3-hour bundle, all elements must be completed by 3 hours.
|
Intervention initiated within 1 hour or 3 hours of presentation depending on the Arm: 1. Measure lactate level.
2. Obtain blood cultures before administering antibiotics.
3. Administer broad-spectrum antibiotics.
4. Begin rapid administration of 30ml/kg crystalloid for hypotension or lactate greater than or equal to 4mmol/L. 5. Apply vasopressor if hypotensive during or after fluid resuscitation to maintain a mean arterial pressure greater than or equal to 65 mm Hg.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 28 days
|
Mortality associated with death from sepsis.
|
28 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1R01HL162954-01 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.